MiR-545-3p/MT1M axis regulates cell proliferation, invasion and migration in hepatocellular carcinoma.

[1]  Juan Fortea,et al.  Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer’s Disease: Potential and Limitations , 2017, Molecular Neurobiology.

[2]  Joon-Oh Park,et al.  Ramucirumab as Second-Line Treatment in Patients With Advanced Hepatocellular Carcinoma: Analysis of REACH Trial Results by Child-Pugh Score , 2017, JAMA oncology.

[3]  Jianwei Ye,et al.  MiR‐24‐3p enhances cell growth in hepatocellular carcinoma by targeting metallothionein 1M , 2016, Cell biochemistry and function.

[4]  Meng Xu,et al.  Ftx non coding RNA-derived miR-545 promotes cell proliferation by targeting RIG-I in hepatocellular carcinoma , 2016, Oncotarget.

[5]  Ge Wang,et al.  MicroRNAs involved with hepatocellular carcinoma (Review). , 2015, Oncology reports.

[6]  J. Niu,et al.  miR-154 targeting ZEB2 in hepatocellular carcinoma functions as a potential tumor suppressor. , 2015, Oncology reports.

[7]  Qingyuan Zhang,et al.  miRNA-24-3p promotes cell proliferation and inhibits apoptosis in human breast cancer by targeting p27Kip1. , 2015, Oncology reports.

[8]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[9]  G. Jin,et al.  miR‐545 inhibited pancreatic ductal adenocarcinoma growth by targeting RIG‐I , 2014, FEBS letters.

[10]  Yahui Liu,et al.  miR‑222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinoma. , 2014, International journal of oncology.

[11]  Y. Ming,et al.  miR-24 promotes the proliferation and invasion of HCC cells by targeting SOX7 , 2014, Tumor Biology.

[12]  G. Calin,et al.  MicroRNAs as therapeutic targets in human cancers , 2014, Wiley interdisciplinary reviews. RNA.

[13]  Shuai Gao,et al.  MT1M and MT1G promoter methylation as biomarkers for hepatocellular carcinoma. , 2014, World journal of gastroenterology.

[14]  W. Gallagher,et al.  microRNAs: a new class of breast cancer biomarkers , 2014, Expert review of molecular diagnostics.

[15]  Angela M. Liu,et al.  miR-122 Targets Pyruvate Kinase M2 and Affects Metabolism of Hepatocellular Carcinoma , 2014, PloS one.

[16]  A. Vecchione,et al.  MicroRNA miR‐24 promotes cell proliferation by targeting the CDKs inhibitors p27Kip1 and p16INK4a , 2013, Journal of cellular physiology.

[17]  V. Adamo,et al.  Circulating miR‐22, miR‐24 and miR‐34a as Novel Predictive Biomarkers to Pemetrexed‐Based Chemotherapy in Advanced Non‐Small Cell Lung Cancer , 2013, Journal of cellular physiology.

[18]  J. Xiong,et al.  Downregulation of miR‐16 promotes growth and motility by targeting HDGF in non‐small cell lung cancer cells , 2013, FEBS letters.

[19]  R. Chang,et al.  MicroRNA‐140‐5p suppresses tumor growth and metastasis by targeting transforming growth factor β receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma , 2013, Hepatology.

[20]  Yanqiao Zhang,et al.  Comparison of percutaneous cryosurgery and surgical resection for the treatment of small hepatocellular carcinoma , 2013, Oncology letters.

[21]  C. Croce,et al.  The Role of microRNAs in the Tumorigenesis of Ovarian Cancer , 2013, Front. Oncol..

[22]  Songshan Jiang,et al.  miR-24-3p and miR-27a-3p promote cell proliferation in glioma cells via cooperative regulation of MXI1. , 2013, International journal of oncology.

[23]  S. Giordano,et al.  MicroRNAs: New tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma? , 2013, Hepatology.

[24]  C. Plass,et al.  Genome-wide epigenetic regulation of miRNAs in cancer. , 2013, Cancer research.

[25]  M. Zaman,et al.  Current status and implications of microRNAs in ovarian cancer diagnosis and therapy , 2012, Journal of Ovarian Research.

[26]  Jingde Zhu,et al.  Metallothionein MT1M is a tumor suppressor of human hepatocellular carcinomas. , 2012, Carcinogenesis.

[27]  G. De Petro,et al.  Human hepatocellular carcinoma cell-specific miRNAs reveal the differential expression of miR-24 and miR-27a in cirrhotic/non-cirrhotic HCC , 2012, International journal of oncology.

[28]  V. Adam,et al.  Mammalian metallothioneins: properties and functions. , 2012, Metallomics : integrated biometal science.

[29]  Kwang-Huei Lin,et al.  Identification of Postoperative Prognostic MicroRNA Predictors in Hepatocellular Carcinoma , 2012, PloS one.

[30]  P. Zhang,et al.  MicroRNA-99a Inhibits Hepatocellular Carcinoma Growth and Correlates with Prognosis of Patients with Hepatocellular Carcinoma* , 2011, The Journal of Biological Chemistry.

[31]  J. Kao,et al.  Prevention of hepatocellular carcinoma in the Asia–Pacific region: Consensus statements , 2010, Journal of gastroenterology and hepatology.

[32]  M. Stoltenberg,et al.  The role of metallothionein in oncogenesis and cancer prognosis. , 2009, Progress in histochemistry and cytochemistry.

[33]  Kuo-Bin Li,et al.  Profiling MicroRNA Expression in Hepatocellular Carcinoma Reveals MicroRNA-224 Up-regulation and Apoptosis Inhibitor-5 as a MicroRNA-224-specific Target* , 2008, Journal of Biological Chemistry.

[34]  Shu-Hui Zhang,et al.  Downregulated expression of metallothionein and its clinicopathological significance in hepatocellular carcinoma , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

[35]  K. Ghoshal,et al.  Metallothionein expression is suppressed in primary human hepatocellular carcinomas and is mediated through inactivation of CCAAT/enhancer binding protein alpha by phosphatidylinositol 3-kinase signaling cascade. , 2007, Cancer research.

[36]  Jingde Zhu.  DNA methylation and hepatocellular carcinoma. , 2006, Journal of hepato-biliary-pancreatic surgery.

[37]  S. Theocharis,et al.  Metallothionein expression in human neoplasia , 2004, Histopathology.

[38]  K. Ghoshal,et al.  Suppression of metallothionein-I/II expression and its probable molecular mechanisms. , 2002, Environmental health perspectives.

[39]  Geng-Wen Huang,et al.  Metallothionein expression in hepatocellular carcinoma. , 2002, World journal of gastroenterology.

[40]  J. H. Beattie,et al.  Induction, Regulation, Degradation, and Biological Significance of Mammalian Metallothioneins , 2000, Critical reviews in biochemistry and molecular biology.

[41]  C. Tohyama,et al.  Metallothionein in radiation exposure: its induction and protective role. , 1999, Toxicology.

[42]  M. Cherian,et al.  Metallothionein and apoptosis in primary human hepatocellular carcinoma (HCC) from northern China. , 1998, Anticancer research.

[43]  F. Stennard,et al.  Characterisation of six additional human metallothionein genes. , 1994, Biochimica et biophysica acta.

[44]  Junrong Liang,et al.  MicroRNA-542-3p inhibits the growth of hepatocellular carcinoma cells by targeting FZD7/Wnt signaling pathway. , 2017, Biochemical and biophysical research communications.

[45]  Thomas Tuschl,et al.  MicroRNAs in human cancer. , 2013, Advances in experimental medicine and biology.

[46]  H. Forman,et al.  Oxidants as stimulators of signal transduction. , 1997, Free radical biology & medicine.